Efficacy and tolerability of treatment with mirabegron compared with solifenacin in the management of overactive bladder syndrome: A retrospective analysis-Reference-Cited by-同舟云学术

Efficacy and tolerability of treatment with mirabegron compared with solifenacin in the management of overactive bladder syndrome: A retrospective analysis

Published:2017-12-22 Issue:3 Volume:44 Page:524-531
ISSN:1341-8076
Container-title:Journal of Obstetrics and Gynaecology Research
language:en
Short-container-title:J. Obstet. Gynaecol. Res.

Author:

Schiavi Michele C.¹^ORCID,Faiano Pierangelo¹,D'Oria Ottavia¹,Zullo Marzio A.²,Muzii Ludovico¹,Benedetti Panici Pierluigi¹

Affiliation:

1. Department of Gynecological-Obstetric Sciences and Urological Sciences; University of Rome “Sapienza,” Umberto I Hospital; Rome Italy

2. Department of Surgery - Week-Surgery Campus Biomedico; University of Rome; Rome Italy

Publisher

Wiley

Subject

Obstetrics and Gynecology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/jog.13541/fullpdf

Reference25 articles.

1. An International Urogynecological Association (IUGA)/International Continence Society (ICS) joint report on the terminology for female pelvic floor dysfunction;Haylen;Int Urogynecol J,2010

2. Prevalence and burden of overactive bladder in the United States;Stewart;World J Urol,2003

3. How widespread are the symptoms of an overactive bladder and how are they managed? A population-based prevalence study;Milsom;BJU Int,2001

4. Worldwide prevalence estimates of lower urinary tract symptoms, overactive bladder, urinary incontinence and bladder outlet obstruction;Irwin;BJU Int,2011

5. Mirabegron for overactive bladder: A novel, first-in-class β3-agonist therapy;Imran;Urol J,2013

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The impact of pharmacotherapy on sexual function in female patients being treated for idiopathic overactive bladder: a systematic review;BMC Women's Health;2024-05-16

2. Therapeutic effectiveness and adverse drug reactions of mirabegron versus solifenacin in the treatment of overactive bladder syndrome;Perspectives in Clinical Research;2024-05-16

3. TOT in combination with solifenacin or intravaginal prasterone in postmenopausal women with mixed urinary incontinence: A retrospective analysis in 112 patients;LUTS: Lower Urinary Tract Symptoms;2023-03-04

4. The Efficacy of Fractional CO2 Laser in the Treatment of Genitourinary Syndrome of Menopause: A Large Prospective Observational Study;Clinical and Experimental Obstetrics & Gynecology;2022-09-07

5. Comparison of antimuscarinic drugs to beta adrenergic agonists in overactive bladder: A literary review;Current Urology;2021-08-17